General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-15 | 2024-03 | 0 | -15.4 | N/A | N/A |
2024-03-18 | 2023-12 | 0 | 42.11 | N/A | N/A |
2023-11-13 | 2023-09 | 0 | 4.51 | N/A | N/A |
2023-08-10 | 2023-06 | 0 | -39.1 | N/A | N/A |
2023-05-12 | 2023-03 | 0 | -103.01 | N/A | N/A |
2023-03-30 | 2022-12 | 0 | 92.48 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-04-02 | Aegis Capital | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-12-10 | DAVIDOW ROBERT L | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2024-04-15 | FORTRESS BIOTECH, INC. | Beneficial Owner of more than 10% of a Class of Security | 3.55M | Stock Award(Grant) |
2021-12-16 | HERSKOWITZ NEIL | Director | 183.74K | Stock Award(Grant) |
2019-09-11 | INGRAM ELIZABETH GARRETT | Director | 16.00K | Purchase |
2022-10-10 | INVAGEN PHARMACEUTICALS, INC. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2021-12-16 | KRANZLER JAY D | Director | 133.68K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Sabby Management, LLC | 553.34K | 647.41K | 6.17% |
2023-06-29 | Bank Of New York Mellon Corporation | 52.99K | 61.99K | 0.59% |
2023-06-29 | Geode Capital Management, LLC | 52.57K | 61.51K | 0.59% |
2023-06-29 | State Street Corporation | 30.59K | 35.79K | 0.34% |
2023-06-29 | Shikiar Asset Management, Inc. | 25.00K | 29.25K | 0.28% |
2023-06-29 | Tower Research Capital LLC (TRC) | 5.63K | 6.59K | 0.06% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 9.08K | 10.63K | 0.10% |
2023-05-30 | Fidelity Series Total Market Index Fund | 6.24K | 6.77K | 0.07% |
2023-05-30 | Fidelity Extended Market Index Fund | 3.51K | 3.81K | 0.04% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 1.27K | 1.38K | 0.01% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 513.00 | 398.00 | 0.01% |
Split | Date |
---|---|
1 : 75 | 2024-04-26 |
1 : 15 | 2022-09-23 |
Only 5 ml mkt value at this price, WTF too risky this stock…going to delisting soon!!!
Come to jcse ready to fly
IM OUT…….. gonna start the next run with $AVCT. Good luck to everyone